Parallel Advisors, LLC Novartis Ag Transaction History

Parallel Advisors, LLC

  • $3.87 Billion
  • Q2 2024

A detailed history of Parallel Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Parallel Advisors, LLC holds 12,946 shares of NVS stock, worth $1.43 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,946
Previous 12,050 7.44%
Holding current value
$1.43 Million
Previous $1.17 Million 18.28%
% of portfolio
0.04%
Previous 0.03%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$92.57 - $107.37 $82,942 - $96,203
896 Added 7.44%
12,946 $1.38 Million
Q1 2024

May 06, 2024
BUY
$95.27 - $108.47 $302,863 - $344,826
3,179 Added 35.84%
12,050 $1.17 Million
Q4 2023

Feb 09, 2024
SELL
$92.27 - $101.54 $21,683 - $23,861
-235 Reduced 2.58%
8,871 $895,000
Q3 2023

May 20, 2024
BUY
$94.73 - $105.13 $28,229 - $31,328
298 Added 3.38%
9,106 $927,000
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $28,229 - $31,328
298 Added 3.38%
9,106 $927,000
Q2 2023

May 20, 2024
BUY
$92.52 - $104.91 $70,500 - $79,941
762 Added 9.47%
8,808 $888,000
Q2 2023

Aug 04, 2023
BUY
$92.52 - $104.91 $70,500 - $79,941
762 Added 9.47%
8,808 $888,000
Q1 2023

May 20, 2024
SELL
$80.03 - $92.81 $320,440 - $371,611
-4,004 Reduced 33.23%
8,046 $740,000
Q1 2023

Apr 25, 2023
BUY
$80.03 - $92.81 $56,421 - $65,431
705 Added 9.6%
8,046 $740,000
Q4 2022

Feb 03, 2023
SELL
$75.55 - $92.52 $4,759 - $5,828
-63 Reduced 0.85%
7,341 $665,000
Q3 2022

Nov 10, 2022
SELL
$74.61 - $87.26 $57,524 - $67,277
-771 Reduced 9.43%
7,404 $563,000
Q2 2022

Aug 01, 2022
SELL
$80.52 - $93.75 $172,151 - $200,437
-2,138 Reduced 20.73%
8,175 $691,000
Q1 2022

Apr 28, 2022
SELL
$80.11 - $90.62 $134,905 - $152,604
-1,684 Reduced 14.04%
10,313 $907,000
Q4 2021

Jan 20, 2022
SELL
$79.7 - $88.13 $151,430 - $167,447
-1,900 Reduced 13.67%
11,997 $1.05 Million
Q3 2021

Nov 02, 2021
BUY
$81.78 - $95.14 $173,618 - $201,982
2,123 Added 18.03%
13,897 $1.14 Million
Q2 2021

Aug 06, 2021
BUY
$85.24 - $94.15 $296,976 - $328,018
3,484 Added 42.03%
11,774 $1.07 Million
Q1 2021

Apr 23, 2021
BUY
$83.5 - $98.47 $40,581 - $47,856
486 Added 6.23%
8,290 $709,000
Q4 2020

Feb 02, 2021
BUY
$78.07 - $94.43 $12,256 - $14,825
157 Added 2.05%
7,804 $737,000
Q3 2020

Oct 27, 2020
BUY
$82.14 - $91.0 $68,504 - $75,894
834 Added 12.24%
7,647 $665,000
Q2 2020

Jul 16, 2020
BUY
$80.93 - $91.1 $116,377 - $131,001
1,438 Added 26.75%
6,813 $595,000
Q1 2020

Apr 27, 2020
SELL
$70.67 - $99.01 $94,556 - $132,475
-1,338 Reduced 19.93%
5,375 $443,000
Q4 2019

Jan 30, 2020
BUY
$84.35 - $95.37 $5,482 - $6,199
65 Added 0.98%
6,713 $636,000
Q3 2019

Nov 01, 2019
BUY
$85.54 - $94.26 $137,120 - $151,098
1,603 Added 31.77%
6,648 $578,000
Q2 2019

Aug 05, 2019
BUY
$75.4 - $92.8 $7,917 - $9,744
105 Added 2.13%
5,045 $461,000
Q1 2019

May 01, 2019
BUY
$75.32 - $86.15 $105,372 - $120,523
1,399 Added 39.51%
4,940 $475,000
Q4 2018

Feb 05, 2019
BUY
$73.66 - $82.02 $49,278 - $54,871
669 Added 23.29%
3,541 $303,000
Q3 2018

Nov 01, 2018
BUY
$66.94 - $77.43 $3,882 - $4,490
58 Added 2.06%
2,872 $247,000
Q2 2018

Jul 30, 2018
SELL
$64.91 - $73.36 $67,766 - $76,587
-1,044 Reduced 27.06%
2,814 $212,000
Q1 2018

May 08, 2018
BUY
$70.39 - $84.15 $8,165 - $9,761
116 Added 3.1%
3,858 $312,000
Q4 2017

Feb 13, 2018
BUY
$72.33 - $77.64 $4,050 - $4,347
56 Added 1.52%
3,742 $314,000
Q3 2017

Nov 15, 2017
BUY
$74.14 - $77.27 $273,280 - $284,817
3,686 New
3,686 $305,000
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $272,390 - $283,889
-3,674 Closed
0 $0
Q2 2017

Aug 07, 2017
BUY
N/A
3,674
3,674 $313,000

Others Institutions Holding NVS

# of Institutions
1,434
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.55M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email